Fuji Pharma Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Takayuki Iwai
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.3yrs |
| CEO ownership | 0.04% |
| Management average tenure | no data |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
CEO
Takayuki Iwai (59 yo)
5.3yrs
Tenure
Mr. Takayuki Iwai is President & CEO of Fuji Pharma Co., Ltd. from November 2019. He joined the Fuji Pharma Co., Ltd.in October 2019. He was President of Fuji Pharma Co., Ltd. from 2019 to November 2019.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| VP, Executive Officer & Director | no data | no data | 0.079% ¥ 30.8m | |
| Chairman | 33.4yrs | no data | 34.38% ¥ 13.4b | |
| Outside Audit & Supervisory Board Member | 20.4yrs | no data | 0.030% ¥ 11.8m | |
| Vice President & Director | 1.4yrs | no data | 0.00019% ¥ 74.0k | |
| Independent Outside Director | 7.4yrs | no data | 0.021% ¥ 8.3m | |
| Director | less than a year | no data | 0.0059% ¥ 2.3m | |
| Independent Outside Director | 6.4yrs | no data | 0.021% ¥ 8.3m | |
| Outside Audit & Supervisory Board Member | 4.4yrs | no data | 0.0045% ¥ 1.8m | |
| Independent Outside Director | 3.4yrs | no data | 0.0021% ¥ 801.8k | |
| Independent Outside Director | 3.4yrs | no data | 0.00082% ¥ 319.2k | |
| Audit & Supervisory Board Chairman | no data | no data | 0.033% ¥ 12.8m |
4.4yrs
Average Tenure
60yo
Average Age
Experienced Board: 4554's board of directors are considered experienced (4.4 years average tenure).